Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Influence of FK 506 (tacrolimus) on circulating CD4+ T cells expressing CD25 and CD45RA antigens in 19 patients with chronic progressive multiple sclerosis participating in an open label drug safety trial.

Lemster B, Huang LL, Irish W, Woo J, Carroll PB, Abu-Elmagd K, Rilo HR, Johnson N, Russell-Hall R, Fung JJ, et al. Influence of FK 506 (tacrolimus) on circulating CD4+ T cells expressing CD25 and CD45RA antigens in 19 patients with chronic progressive multiple sclerosis participating in an open label drug safety trial. Autoimmunity. 1994; 19(2):89-98.

View in: PubMed

collapse authors with profiles